Globus Medical Inc

Q2 FY2026 EarningsQ2 FY2026 results significantly exceeded consensus expectations across the board: revenue of $789.6M beat the $783.0M forecast, while non-GAAP diluted EPS of $1.34 substantially outperformed the $1.10 mean estimate. Adjusted gross margin reached 69.4%, a 200 bps YoY expansion driven by synergy realization and pricing discipline. Management reaffirmed FY26 revenue guidance ($3.18B - $3.22B) and raised non-GAAP EPS guidance to $4.95 - $5.05, signaling strong momentum in US Spine and International markets.